Entia Biosciences Developing ErgoD2(TM) Line of Medical Foods
2/27/2012 10:07:53 AM
SHERWOOD, Ore., Feb. 24, 2012 (GLOBE NEWSWIRE) -- Entia Biosciences, Inc. (OTCBB:ERGOD) (ENTIA) announced today that it is developing a line of medical food products based on its proprietary ErgoD2™ whole-food formulations. ErgoD2™ is a 100% vegan and USDA certified organic formulation from mushrooms that have been enhanced with the Company's patent pending UV light technology and contain naturally high concentrations of the powerful antioxidants Ergothioneine and Ergocalciferol (vitamin D2). Entia recently announced that it had successfully completed an LD50 toxicity study with the ErgoD2™ formulation and intends to now conduct human studies to further validate the therapeutic and safety claims of its initial medical food products: ErgoD2™ "Hemo" for treatment of anemia and diabetes and ErgoD2™ "Hair" for treatment of Alopecia (hair loss). Other new medical food products are expected to be added to the development pipeline in the coming months.